Daniel N. Swisher, Jr

2021 - Jazz Pharmaceuticals

In 2021, Daniel N. Swisher, Jr earned a total compensation of $5.4M as President at Jazz Pharmaceuticals, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$540,000
Salary$711,154
Stock Awards$4,136,737
Other$16,001
Total$5,403,892

Swisher received $4.1M in stock awards, accounting for 77% of the total pay in 2021.

Swisher also received $540K in non-equity incentive plan, $711.2K in salary and $16K in other compensation.

Rankings

In 2021, Daniel N. Swisher, Jr's compensation ranked 2,375th out of 12,406 executives tracked by ExecPay. In other words, Swisher earned more than 80.9% of executives.

ClassificationRankingPercentile
All
2,375
out of 12,406
81st
Division
Manufacturing
937
out of 5,492
83rd
Major group
Chemicals And Allied Products
357
out of 2,368
85th
Industry group
Drugs
310
out of 2,089
85th
Industry
Pharmaceutical Preparations
202
out of 1,536
87th

Pay ratio

Daniel N. Swisher, Jr's Pay$5,403,892
Median Employee's Pay$212,134
Pay Ratio

25

to 1

In 2021, the annual total compensation of Daniel N. Swisher, Jr was $5,403,892.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.

The ratio of Daniel N. Swisher, Jr's pay to the pay of median employee was therefore 25 to one.

Source: SEC filing on June 10, 2022.

Swisher's colleagues

We found four more compensation records of executives who worked with Daniel N. Swisher, Jr at Jazz Pharmaceuticals in 2021.

2021

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2021

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2021

Chris Tovey

Jazz Pharmaceuticals

Chief Operating Officer

2021

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like